These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28125354)

  • 1. Engineered Probiotics: Applications and Biological Containment.
    Sola-Oladokun B; Culligan EP; Sleator RD
    Annu Rev Food Sci Technol; 2017 Feb; 8():353-370. PubMed ID: 28125354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity.
    Ozdemir T; Fedorec AJH; Danino T; Barnes CP
    Cell Syst; 2018 Jul; 7(1):5-16. PubMed ID: 30048620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation biocontainment systems for engineered organisms.
    Lee JW; Chan CTY; Slomovic S; Collins JJ
    Nat Chem Biol; 2018 Jun; 14(6):530-537. PubMed ID: 29769737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering probiotics for therapeutic applications: recent examples and translational outlook.
    Aggarwal N; Breedon AME; Davis CM; Hwang IY; Chang MW
    Curr Opin Biotechnol; 2020 Oct; 65():171-179. PubMed ID: 32304955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic biology approaches to biological containment: pre-emptively tackling potential risks.
    Torres L; Krüger A; Csibra E; Gianni E; Pinheiro VB
    Essays Biochem; 2016 Nov; 60(4):393-410. PubMed ID: 27903826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recoded organisms engineered to depend on synthetic amino acids.
    Rovner AJ; Haimovich AD; Katz SR; Li Z; Grome MW; Gassaway BM; Amiram M; Patel JR; Gallagher RR; Rinehart J; Isaacs FJ
    Nature; 2015 Feb; 518(7537):89-93. PubMed ID: 25607356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic biology: from mainstream to counterculture.
    Sleator RD
    Arch Microbiol; 2016 Sep; 198(7):711-3. PubMed ID: 27316777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically engineered probiotics.
    Steidler L
    Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):861-76. PubMed ID: 14507594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tweak to Treat: Reprograming Bacteria for Cancer Treatment.
    Sieow BF; Wun KS; Yong WP; Hwang IY; Chang MW
    Trends Cancer; 2021 May; 7(5):447-464. PubMed ID: 33303401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of bacteria as diagnostics and therapeutics by genetic engineering.
    Lim D; Song M
    J Microbiol; 2019 Aug; 57(8):637-643. PubMed ID: 31079333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications.
    Bober JR; Beisel CL; Nair NU
    Annu Rev Biomed Eng; 2018 Jun; 20():277-300. PubMed ID: 29528686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient engineered probiotics using synthetic biology approaches: A review.
    Yadav M; Shukla P
    Biotechnol Appl Biochem; 2020 Jan; 67(1):22-29. PubMed ID: 31538358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Genomics: Repurposing Biological Systems for Applications in Engineering Biology.
    Fu X; Shen Y
    ACS Synth Biol; 2024 May; 13(5):1394-1399. PubMed ID: 38757697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering Microbial Living Therapeutics: The Synthetic Biology Toolbox.
    Pedrolli DB; Ribeiro NV; Squizato PN; de Jesus VN; Cozetto DA;
    Trends Biotechnol; 2019 Jan; 37(1):100-115. PubMed ID: 30318171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioengineered probiotics as a new hope for health and diseases: an overview of potential and prospects.
    Kumar M; Yadav AK; Verma V; Singh B; Mal G; Nagpal R; Hemalatha R
    Future Microbiol; 2016; 11(4):585-600. PubMed ID: 27070955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases.
    Meng J; Liu S; Wu X
    Crit Rev Microbiol; 2024 May; 50(3):300-314. PubMed ID: 36946080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic biology and occupational risk.
    Howard J; Murashov V; Schulte P
    J Occup Environ Hyg; 2017 Mar; 14(3):224-236. PubMed ID: 27754800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine adjuvant technology: from mechanistic concepts to practical applications.
    Degen WG; Jansen T; Schijns VE
    Expert Rev Vaccines; 2003 Apr; 2(2):327-35. PubMed ID: 12899582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biosafety risks, control, and biocontainment of engineered microalgae].
    Wang J; Song X; Chen L; Zhang W
    Sheng Wu Gong Cheng Xue Bao; 2024 Sep; 40(9):2948-2967. PubMed ID: 39319717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.